Skip to main content
. 2021 Jul 21;17(7):e1009747. doi: 10.1371/journal.ppat.1009747

Fig 1. Graphic representation of the use of hCOs to study prion diseases.

Fig 1

Organoids permit investigation into various aspects of prion disease including (1) different sCJD subtypes; (2) neuronal dysfunction and death; (3) cellular cross-talk; (4) conversion initiating triggers; and (5) efficacy of putative therapeutics. hCO, human cerebral organoid; PrP, prion protein; sCJD, sporadic Creutzfeldt–Jakob disease.